|1.||Denizot, Yves: 3 articles (05/2006 - 10/2003)|
|2.||Bennett, Steffany A L: 2 articles (12/2009 - 09/2002)|
|3.||Truffinet, Véronique: 2 articles (05/2006 - 07/2005)|
|4.||Mathonnet, Muriel: 2 articles (05/2006 - 07/2005)|
|5.||Raj, J U: 2 articles (11/2001 - 01/2000)|
|6.||Ibe, B O: 2 articles (11/2001 - 01/2000)|
|7.||Flasiński, Michał: 1 article (06/2014)|
|8.||Hąc-Wydro, Katarzyna: 1 article (06/2014)|
|9.||Wydro, Paweł: 1 article (06/2014)|
|10.||Dynarowicz-Łątka, Patrycja: 1 article (06/2014)|
|1.||Myocardial Ischemia (Ischemic Heart Diseases)
10/01/1998 - "Considering normal plasma levels of PAF and lyso-PAF, and lack of evidence that anti-PAF antibodies are really beneficial in myocardial ischemia-reperfusion, it is reasonable to speculate that an inability of systemic PAF to 'turn on' PAF-AH enzymatic activity could contribute substantially to the observed events. "
06/01/1992 - "Myocardial ischemia is associated with accumulation of lyso-phospholipids, including lyso-platelet activating factor, the degradation product and precursor of platelet activating factor. "
|2.||Crohn Disease (Crohn's Disease)
09/01/1992 - "Lyso platelet activating factor and alkyl acyl glycerophosphocholine were not significantly higher in Crohn's disease than in controls. "
09/01/1992 - "Platelet activating factor, lyso platelet activating factor, and alkyl acyl glycerophosphocholine were found in patients with acute Crohn's disease and in remission as well as in controls. "
09/01/1992 - "Platelet activating factor, lyso platelet activating factor, and alkyl acyl glycerophosphocholine, were determined in colonic mucosal biopsies in patients with acute Crohn's disease, during prednisolone therapy, and in remission. "
01/01/1993 - "The results obtained from this study suggest that the turnover of lyso-PAF to PAF may play a role in evoking prolonged inflammation in target organs or tissues."
01/01/1987 - "The significance of the higher level of lyso-PAF in the pouch fluid in the anaphylactic phase of allergic inflammation is discussed."
05/01/1990 - "Platelets and leukocytes are known to degrade platelet-activating factor (PAF), a potential mediator of inflammation, to its lyso-derivative (lyso-PAF) and then convert this to 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholines. "
05/01/1999 - "In order to investigate further the role of platelet activating factor in intraocular inflammation, we have characterized the histological changes associated with the intravitreal injection of platelet activating factor, PAF analogs, or lyso-PAF in laboratory rabbits and rats. "
09/01/2001 - "We find that commercial lysophosphatidylcholine, its alkyl homolog (lyso-PAF), and PAF all induce inflammation in a murine model of pleurisy. "
07/01/1994 - "Previous studies have shown that allergen challenge of patients with allergic rhinitis leads to an increase of the concentrations of lyso-PAF in nasal lavage fluid (NLF), whereas PAF is detected only marginally. "
08/01/1994 - "Ten patients with allergic rhinitis and 10 normal subjects underwent nasal challenge with PAF (500 nmol), lyso-PAF (500 nmol) and saline solution. "
08/01/1991 - "In 6 normal subjects and 6 patients with allergic rhinitis, nasal response to insufflation of paf-acether (paf, platelet-activating factor), lyso-paf and histamine was evaluated. "
|5.||Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
02/01/2001 - "These results suggest that PAF in the tear fluid is quickly hydrolyzed to lyso-PAF by PAF AH, which may be released or activated in allergic conjunctivitis."
10/01/2006 - "The aim of this study was to examine the levels of platelet-activating factor (PAF) and lyso-PAF in tears from experimental animals developing allergic conjunctivitis (AC). "
|1.||Platelet Activating Factor
|6.||Phospholipases A2 (Phospholipase A2)
|8.||Fatty Acids (Saturated Fatty Acids)
|10.||1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)